+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nitinol Medical Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912228

Quick Summary:

In the ever-evolving landscape of medical technology, the necessity for innovative and efficient medical devices is paramount. The global nitinol medical devices market caters to this demand, leveraging the unique properties of a cutting-edge shape memory alloy. Nitinol, known for its superelasticity and phase transformation abilities, is at the core of significant advancements in medical device engineering. As the adoption of minimally invasive procedures continues to rise, the reliance on nitinol-based instruments, from catheters to guidewires, is growing apace.

For discerning senior business executives, understanding the dynamics of the nitinol medical devices market is crucial. With comprehensive insights into product segmentation, ranging from cardiovascular stents to orthopedic applications, and detailed coverage of emerging market trends and demographic shifts, this report stands as an invaluable tool for strategic decision-making. It captures the intricacies of market forces and provides a thorough analysis of the competitive landscape, unfolding lucrative opportunities and aiding in the formulation of impactful growth strategies.

The global nitinol medical devices market size reached US$ 17.8 Billion in 2022. Looking forward, the market is expected to reach US$ 27.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.52% during 2022-2028.

Nitinol belongs to a class of shape memory alloys (SMA) made using equal concentrations of nickel and titanium. It is a super elastic material with the ability of phase transformation from austenite to martensite and back to the stress-free austenite state. It is widely used to develop medical devices that undergo repetitive deformations from high strain levels during deployment. Some of the commonly used nitinol medical devices include catheter tubes, guidewires, stone retrieval baskets, filters, needles, dental files, arch wires, and other surgical instruments. At present, these medical devices find extensive applications in minimally invasive (MI) procedures around the world.

Nitinol Medical Devices Market Trends

There is a significant increase in the prevalence of chronic and cardiovascular diseases worldwide on account of sedentary lifestyles and the rising number of individuals who consume alcohol excessively and smoke. This, in confluence with the growing geriatric population, which is more susceptible to medical ailments, represents one of the key factors driving the market. Apart from this, the increasing adoption of minimally invasive surgeries (MIS) on account of its numerous benefits, including smaller incisions, less scarring, considerable accuracy, and decreased risk of complications, is positively influencing the utilization of nitinol medical devices across the globe. Furthermore, leading manufacturers are introducing advanced nitinol medical devices like peripheral vascular stents that find extensive applications in general surgery, structural heart diseases, and orthopedics. They are also focusing on developing material technology to offer better radiopacity, higher strength, enhanced purity, and tighter transformational hysteresis, which is creating a favorable market outlook. Other major factors, including the introduction of biodegradable polymer stents and growing applications of nitinol medical devices in orthodontics and endodontics, are anticipated to fuel the market growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global nitinol medical devices market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product type, application and end user.

Breakup by Product Type:

  • Stents
  • Baskets
  • Guidewires
  • Nitinol Catheters
  • Nitinol Filters

Breakup by Application:

  • Cardiovascular
  • Urology
  • Dentistry
  • Gastroenterology

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Endosmart GmbH, Medtronic plc, Shanghai MicroPort Medical (Group) Co. Ltd., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc. and Zimmer Biomet.

Key Questions Answered in This Report:

  • How has the global nitinol medical devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nitinol medical devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nitinol medical devices market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Nitinol Medical Devices Market

What is the estimated value of the Global Nitinol Medical Devices Market?

The Global Nitinol Medical Devices Market was estimated to be valued at $17.8 Billion in 2022.

What is the growth rate of the Global Nitinol Medical Devices Market?

The growth rate of the Global Nitinol Medical Devices Market is 7.5%, with an estimated value of $27.5 Billion by 2028.

What is the forecasted size of the Global Nitinol Medical Devices Market?

The Global Nitinol Medical Devices Market is estimated to be worth $27.5 Billion by 2028.

Who are the key companies in the Global Nitinol Medical Devices Market?

Key companies in the Global Nitinol Medical Devices Market include Akzo Nobel N.V., Arkema S.A., BASF SE, Celanese Corporation, Dow Inc., DuPont de Nemours Inc., Huntsman Corporation, Lanxess AG, LyondellBasell Industries N.V. and Mitsubishi Gas Chemical Company Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nitinol Medical Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Baskets
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Guidewires
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nitinol Catheters
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Nitinol Filters
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Application
7.1 Cardiovascular
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Urology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dentistry
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Gastroenterology
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arthrex Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 B. Braun Melsungen AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Boston Scientific Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cook Group Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Endosmart GmbH
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Shanghai MicroPort Medical (Group) Co. Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Stryker Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Terumo Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 W. L. Gore & Associates Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 SWOT Analysis
14.3.12 Zimmer Biomet
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

Companies Mentioned

  • Arthrex Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Endosmart GmbH
  • Medtronic plc
  • Shanghai MicroPort Medical (Group) Co. Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates Inc.
  • Zimmer Biomet

Methodology

Loading
LOADING...